Recruiting

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years

ClinicalTrials.gov IDNCT03390894

PhaseNot Applicable

Enrollment8000

SponsorSpanish Breast Cancer Research Group

Age18 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Invasive Breast Cancer Early Stages

About this study

Primary outcomes

Event Free Survival (EvFS) in neoadjuvant studies. (Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.)
Disease Free Survival (DFS) in adjuvant studies. (Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.)

Eligibility information

Inclusion Criteria: * Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected. * Patients whose death or contact loss has not been previously collected in the databases of the original studies. Exclusion Criteria: * Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.

Study locations

Complejo Hospitalario de Navarra, Pamplona, Navarre Spain
Hospital San Agustín Avilés, Avilés, Principality of Asturias Spain
Hospital Universitario de Canarias, San Cristóbal de La Laguna, Tenerife Spain
Centro Oncológico de Galicia, A Coruña, Spain
Complejo Hospitalario A Coruña, A Coruña, Spain
Complejo Hospitalario Universitario de Albacete, Albacete, Spain
Hospital General Universitario de Alicante, Alicante, Spain
Hospital General Universitario de Elche, Alicante, Spain
Hospital General Universitario de Elda, Alicante, Spain
Hospital Virgen De Los Lirios, Alicante, Spain

Showing 10 of 73 reported sites. See the official listing for all locations.

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.